Search Results

ML364 25 mg  | 100.00%

TargetMol

ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2) and can be used for the research of breast cancer.

More Information Supplier Page

ML364 10 mg  | 100.00%

TargetMol

ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2) and can be used for the research of breast cancer.

More Information Supplier Page

Y16 5 mg  | Purity Not Available

TargetMol

Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated signaling functions.

More Information Supplier Page

Y16 10 mg  | Purity Not Available

TargetMol

Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated signaling functions.

More Information Supplier Page

Epacadostat 5 mg  | 98.56%

TargetMol

Epacadostat is an oral-available inhibitor of indoleamine 2, 3-dioxygenase (IDO1), increasing the proliferation and activation of various immune cells and reducing tumor-associated regulatory T cells.

More Information Supplier Page

Epacadostat 50 mg  | 98.56%

TargetMol

Epacadostat is an oral-available inhibitor of indoleamine 2, 3-dioxygenase (IDO1), increasing the proliferation and activation of various immune cells and reducing tumor-associated regulatory T cells.

More Information Supplier Page

ML364 50 mg  | 100.00%

TargetMol

ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2) and can be used for the research of breast cancer.

More Information Supplier Page

ML364 5 mg  | 100.00%

TargetMol

ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2) and can be used for the research of breast cancer.

More Information Supplier Page

PLX8394 10 mg  | 100.00%

TargetMol

PLX8394 is an orally active inhibitor of serine/threonine-protein kinase B-Raf (BRAF) protein. PLX8394 can selectively bind to and inhibit the activity of both wild-type and mutated forms of BRAF, then inhibit the proliferation of tumor cells which express mutated forms of BRAF. PLX8394 appears to be effective against tumors that express multiple mutated forms of […]

More Information Supplier Page